Kaczor-Kaminska M, Kaszuba K, Bilska-Wilkosz A, Iciek M, Wrobel M, Kaminski K
Antioxidants (Basel). 2024; 13(5).
PMID: 38790687
PMC: 11117631.
DOI: 10.3390/antiox13050582.
Bora P, Manna S, Nair M, Sathe R, Singh S, Sreyas Adury V
Chem Sci. 2021; 12(39):12939-12949.
PMID: 34745524
PMC: 8513928.
DOI: 10.1039/d1sc03828a.
Zuhra K, Szabo C
FEBS J. 2021; 289(9):2481-2515.
PMID: 34297873
PMC: 9291117.
DOI: 10.1111/febs.16135.
Rossi M, Martinez V, Hinchliffe P, Mojica M, Castillo V, Moreno D
Chem Sci. 2021; 12(8):2898-2908.
PMID: 34164056
PMC: 8179362.
DOI: 10.1039/d0sc05172a.
Janik-Hazuka M, Kaminski K, Kaczor-Kaminska M, Szafraniec-Szczesny J, Kmak A, Kassassir H
Nanomaterials (Basel). 2021; 11(5).
PMID: 34065497
PMC: 8160828.
DOI: 10.3390/nano11051354.
The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.
Divakaran S, Loscalzo J
J Am Coll Cardiol. 2017; 70(19):2393-2410.
PMID: 29096811
PMC: 5687289.
DOI: 10.1016/j.jacc.2017.09.1064.
An Official American Thoracic Society Workshop Report: Chemical Inhalational Disasters. Biology of Lung Injury, Development of Novel Therapeutics, and Medical Preparedness.
Summerhill E, Hoyle G, Jordt S, Jugg B, Martin J, Matalon S
Ann Am Thorac Soc. 2017; 14(6):1060-1072.
PMID: 28418689
PMC: 5529138.
DOI: 10.1513/AnnalsATS.201704-297WS.
In-vitro mercaptopyruvate sulfurtransferase species comparison in humans and common laboratory animals.
Moeller B, Crankshaw D, Briggs J, Nagasawa H, Patterson S
Toxicol Lett. 2017; 274:64-68.
PMID: 28412453
PMC: 5505176.
DOI: 10.1016/j.toxlet.2017.04.005.
Development of sulfanegen for mass cyanide casualties.
Patterson S, Moeller B, Nagasawa H, Vince R, Crankshaw D, Briggs J
Ann N Y Acad Sci. 2016; 1374(1):202-9.
PMID: 27308865
PMC: 4940216.
DOI: 10.1111/nyas.13114.
Past, present and future of cyanide antagonism research: From the early remedies to the current therapies.
Petrikovics I, Budai M, Kovacs K, Thompson D
World J Methodol. 2015; 5(2):88-100.
PMID: 26140275
PMC: 4482825.
DOI: 10.5662/wjm.v5.i2.88.
Sodium nitroprusside in 2014: A clinical concepts review.
Hottinger D, Beebe D, Kozhimannil T, Prielipp R, Belani K
J Anaesthesiol Clin Pharmacol. 2014; 30(4):462-71.
PMID: 25425768
PMC: 4234779.
DOI: 10.4103/0970-9185.142799.
Determination of 3-mercaptopyruvate in rabbit plasma by high performance liquid chromatography tandem mass spectrometry.
Stutelberg M, Vinnakota C, Mitchell B, Monteil A, Patterson S, Logue B
J Chromatogr B Analyt Technol Biomed Life Sci. 2014; 949-950:94-8.
PMID: 24480329
PMC: 3989840.
DOI: 10.1016/j.jchromb.2014.01.006.
Cyanide antidotes for mass casualties: water-soluble salts of the dithiane (sulfanegen) from 3-mercaptopyruvate for intramuscular administration.
Patterson S, Monteil A, Cohen J, Crankshaw D, Vince R, Nagasawa H
J Med Chem. 2013; 56(3):1346-9.
PMID: 23301495
PMC: 3575131.
DOI: 10.1021/jm301633x.
Noninvasive monitoring of treatment response in a rabbit cyanide toxicity model reveals differences in brain and muscle metabolism.
Kim J, Lee J, Mahon S, Mukai D, Patterson S, Boss G
J Biomed Opt. 2012; 17(10):105005.
PMID: 23223999
PMC: 3603151.
DOI: 10.1117/1.JBO.17.10.105005.
Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium.
Belani K, Singh H, Beebe D, George P, Patterson S, Nagasawa H
Anesth Analg. 2012; 114(5):956-61.
PMID: 22392971
PMC: 3334426.
DOI: 10.1213/ANE.0b013e31824c4eb5.
The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning.
Chan A, Crankshaw D, Monteil A, Patterson S, Nagasawa H, Briggs J
Clin Toxicol (Phila). 2011; 49(5):366-73.
PMID: 21740135
PMC: 3882312.
DOI: 10.3109/15563650.2011.584879.
Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity.
Brenner M, Kim J, Lee J, Mahon S, Lemor D, Ahdout R
Toxicol Appl Pharmacol. 2010; 248(3):269-76.
PMID: 20705081
PMC: 3382974.
DOI: 10.1016/j.taap.2010.08.002.
A novel paradigm for assessing efficacies of potential antidotes against neurotoxins in mice.
Crankshaw D, Goon D, Briggs J, DeLong D, Kuskowski M, Patterson S
Toxicol Lett. 2007; 175(1-3):111-7.
PMID: 18024011
PMC: 2171362.
DOI: 10.1016/j.toxlet.2007.10.001.